Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2026-01-05 00:00:00 ET · period of report 2026-01-01 · accession 0001838733-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | 2026-01-01 | CLOV | Toy Andrew | CEO, Dir | F - Tax | $2.35 | -268.0K | 9.57M | -3% | -$629.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-01-01 | F | D | 267,958 | $2.35 | 9,569,489 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 1, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. |